News
Hosted on MSN12mon
Varying performance between different mechanical cardiac valves evaluated by researchersAortic valve disease is a disease where that the valve which is located between the heart and the aorta is not ... "In our study, we have identified a model of mechanical aortic valves which ...
The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...
If you have aortic regurgitation, the flaps around your aortic valve — the valve that pumps blood to your heart — don’t close fully. This causes blood to leak back into your left heart chamber.
The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.
4d
News-Medical.Net on MSNElectronic alerts could improve survival for patients with severe aortic stenosisA new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...
The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the progression of fibrocalcific aortic valve stenosis in phase I and II studies.
Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.
But six months later I had a routine health check and was told I had a heart murmur and must see a cardiologist. He discovered that my aortic valve was leaking and said he would monitor my situation.
As mentioned previously, medically managed treatment of severe aortic stenosis has a dismal prognosis, with an overall mean survival of 3 years from the onset of symptoms. [11,12] Surgical valve ...
CHICAGO, IL—High-risk older patients with a history of heart failure (HF) who are undergoing transcatheter aortic valve implantation have better outcomes when taking dapagliflozin, results from the ...
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results